Partum - Your Regulatory Partner

Unparalleled quality in Planning, Aligning and Executing of Regulatory strategies to bring assets from laboratory to market

get in touch

Partum Life Sciences (PLS) is a global consulting company that provides Regulatory strategy, writing and operational solutions from early phase drug development to life-cycle management of the product. PLS recognises the challenges, gaps and constantly changing regulatory environment in drug development, hence are able to develop befitting and pragmatic solutions to support and accelerate drug development.

History and Purpose

In the landscape of innovation and continuous requirement for safe and efficacious development of medicines, regulatory requirements have become stringent over time. It has become more relevant than before to deliver safer and efficacious therapies than currently existing options.

Partum’s purpose is to drive regulatory sciences in constantly innovating environment with experience, out of the box thinking and setting precedents. We thrive on keeping our clients up to date with regulations, relevance to their assets and providing solutions to regulatory challenges.

talk to the team

Have abundance of specialist regulatory and scientific knowledge

Excellent working relationships with regional and local Regulatory Authorities

Skilled to build clients regulatory competence and provide training

Cell & Gene and Orphan Therapies

Partum specialises in providing regulatory strategic advice, drafting and submitting challenging regulatory documentation for Cell & Gene and ultra-rare/orphan drug development and registrations.


"Partum will be our go-to regulatory consultancy and I highly recommend them."

Medium-sized Biotechnology Company, United States